COMMUNIQUÉS West-GlobeNewswire

Biocartis Group NV: Study Abstract on Performance of Idylla(TM) RAS tests Selected for Oral Presentation at 70th AACC Annual Scientific Meeting in Chicago, IL (US)
31/07/2018
PRESS RELEASE : 31 July 2018, 07:00 CEST/14:00 CDT Study Abstract on Performance of Idylla(TM) RAS tests Selected for Oral Presentation at 70th AACC Annual Scientific Meeting in Chicago, IL (US) Mechelen, Belgium, 31 [...]
Progenics Pharmaceuticals Announces FDA Approval for AZEDRA® (iobenguane I 131) to Treat Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paraganglioma
31/07/2018
The First FDA-Approved Treatment for These Rare, Life-Threatening Neuroendocrine Cancers in Patients Aged 12 and Older Company to Host Conference Call Tomorrow at 8:00 AM ET NEW YORK, July 30, 2018 (GLOBE NEWSWIRE) -- [...]
Immutep’s LAG-3 Immunostimulant Product Candidate, Efti, Receives IND Approval From U.S. FDA
31/07/2018
On schedule to initiate the TACTI-002 Phase II clinical study in 2H 2018 SYDNEY, Australia, July 30, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”) is pleased to announce [...]
MacroGenics Announces Date of Second Quarter 2018 Financial Results Conference Call
31/07/2018
ROCKVILLE, MD, July 30, 2018 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Tuesday, August 7, 2018, the Company will release its financial results for the quarter ended June 30, 2018. [...]
Cannabix Technologies Comments on Bill C-46 – Unaware of any Material Change
31/07/2018
The Cannabix Marijuana Breathalyzer is being developed to provide law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, July 30, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc [...]
ChemioCare Announces Addition of Three Experienced Team Members
31/07/2018
NEW YORK, July 30, 2018 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a biotech company focused on transforming chemotherapy induced nausea and vomiting (CINV) outcomes through transdermal [...]
CreekView Health Center Named Great Place to Work
30/07/2018
PLEASANTON, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- CreekView Health Center in Pleasanton, California, has been certified as a top workplace by the independent research and consulting firm Great Place to Work ®. Great [...]
MPX Postpones Filing Date of 2018 Annual Statements
30/07/2018
Company to reschedule conference call with shareholders upon finalization of financial results TORONTO, July 30, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) [...]
Novartis marks a new era for migraine patients with the EU approval of Aimovig®, a first-of-its-kind treatment specifically designed for migraine prevention
30/07/2018
Patients on Aimovig (erenumab) in clinical trials reported consistent and sustained migraine prevention, with many experiencing a 50% or more reduction in monthly migraine days; safety and tolerability were similar to [...]
Flexion Therapeutics to Report Second-Quarter 2018 Financial Results on August 7, 2018
30/07/2018
BURLINGTON, Mass., July 30, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its second-quarter 2018 financial results after the close of the U.S. financial markets [...]
Retrophin Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
30/07/2018
SAN DIEGO, July 30, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the appointment of Noah L. Rosenberg, M.D., as chief medical officer, where he will oversee the clinical development of [...]
Kura Oncology to Report Second Quarter 2018 Financial Results
30/07/2018
SAN DIEGO, July 30, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
30/07/2018
RADNOR, Pa., July 30, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
SeaSpine Reports Second Quarter 2018 Financial Results
30/07/2018
Updates 2018 Financial Outlook CARLSBAD, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of [...]
GenMark Diagnostics Reports Second Quarter 2018 Results
30/07/2018
CARLSBAD, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]
Editas Medicine to Host Conference Call Discussing Second Quarter 2018 Corporate Update and Results
30/07/2018
CAMBRIDGE, Mass., July 30, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Monday, August 6, 2018, at 5: [...]
Merit Medical Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
30/07/2018
SOUTH JORDAN, Utah, July 30, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and [...]
CytomX Therapeutics to Announce Second Quarter 2018 Financial Results
30/07/2018
SOUTH SAN FRANCISCO, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
athenahealth Reports Second Quarter Fiscal Year 2018 Results
30/07/2018
Company Achieves Strong Revenue and Earnings Growth; Updates Fiscal Year 2018 Financial Outlook WATERTOWN, Mass., July 30, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN) (“athenahealth” or “we”), a leading [...]

Pages